Logo image of MYPS

PLAYSTUDIOS INC (MYPS) Stock Fundamental Analysis

NASDAQ:MYPS - Nasdaq - US72815G1085 - Common Stock - Currency: USD

1.55  +0.2 (+14.81%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MYPS. MYPS was compared to 71 industry peers in the Entertainment industry. No worries on liquidiy or solvency for MYPS as it has an excellent financial health rating, but there are worries on the profitability. MYPS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MYPS has reported negative net income.
In the past year MYPS had a positive cash flow from operations.
In multiple years MYPS reported negative net income over the last 5 years.
Each year in the past 5 years MYPS had a positive operating cash flow.
MYPS Yearly Net Income VS EBIT VS OCF VS FCFMYPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

MYPS has a worse Return On Assets (-8.88%) than 60.56% of its industry peers.
With a Return On Equity value of -11.72%, MYPS perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
Industry RankSector Rank
ROA -8.88%
ROE -11.72%
ROIC N/A
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
MYPS Yearly ROA, ROE, ROICMYPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

MYPS has a better Gross Margin (74.88%) than 88.73% of its industry peers.
MYPS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for MYPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
MYPS Yearly Profit, Operating, Gross MarginsMYPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYPS has less shares outstanding than it did 1 year ago.
MYPS has less shares outstanding than it did 5 years ago.
There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MYPS Yearly Shares OutstandingMYPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYPS Yearly Total Debt VS Total AssetsMYPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.35 indicates that MYPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.35, MYPS is doing good in the industry, outperforming 70.42% of the companies in the same industry.
There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.35
ROIC/WACCN/A
WACC9.22%
MYPS Yearly LT Debt VS Equity VS FCFMYPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.98 indicates that MYPS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.98, MYPS belongs to the best of the industry, outperforming 84.51% of the companies in the same industry.
MYPS has a Quick Ratio of 2.98. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
MYPS has a Quick ratio of 2.98. This is amongst the best in the industry. MYPS outperforms 85.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.98
MYPS Yearly Current Assets VS Current LiabilitesMYPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

MYPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.62%.
MYPS shows a decrease in Revenue. In the last year, the revenue decreased by -6.90%.
MYPS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.87% yearly.
EPS 1Y (TTM)-84.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-19.43%

3.2 Future

MYPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.82% yearly.
Based on estimates for the next years, MYPS will show a decrease in Revenue. The Revenue will decrease by -5.05% on average per year.
EPS Next Y83.77%
EPS Next 2Y38.49%
EPS Next 3Y30.82%
EPS Next 5YN/A
Revenue Next Year-12.4%
Revenue Next 2Y-5.77%
Revenue Next 3Y-2.88%
Revenue Next 5Y-5.05%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MYPS Yearly Revenue VS EstimatesMYPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MYPS Yearly EPS VS EstimatesMYPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MYPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYPS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYPS Price Earnings VS Forward Price EarningsMYPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MYPS indicates a rather cheap valuation: MYPS is cheaper than 95.77% of the companies listed in the same industry.
92.96% of the companies in the same industry are more expensive than MYPS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.41
EV/EBITDA 1.57
MYPS Per share dataMYPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as MYPS's earnings are expected to grow with 30.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.49%
EPS Next 3Y30.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLAYSTUDIOS INC

NASDAQ:MYPS (5/23/2025, 11:54:53 AM)

1.55

+0.2 (+14.81%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)N/A N/A
Inst Owners38.82%
Inst Owner Change-1.04%
Ins Owners3.56%
Ins Owner Change1.46%
Market Cap194.51M
Analysts52
Price Target2.89 (86.45%)
Short Float %0.67%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-46.18%
Min EPS beat(2)-110.08%
Max EPS beat(2)17.72%
EPS beat(4)2
Avg EPS beat(4)-8.54%
Min EPS beat(4)-110.08%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)-54.68%
EPS beat(12)8
Avg EPS beat(12)18.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.2%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)1.83%
Revenue beat(4)2
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-5.33%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.29%
Revenue beat(12)6
Avg Revenue beat(12)0.39%
Revenue beat(16)8
Avg Revenue beat(16)0.58%
PT rev (1m)0%
PT rev (3m)-12.82%
EPS NQ rev (1m)-8.97%
EPS NQ rev (3m)-319.35%
EPS NY rev (1m)-40%
EPS NY rev (3m)-173.42%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-3.68%
Revenue NY rev (1m)-2.21%
Revenue NY rev (3m)-6.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF 8.41
P/OCF 4.25
P/B 0.79
P/tB 1.92
EV/EBITDA 1.57
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.18
FCFY11.89%
OCF(TTM)0.36
OCFY23.52%
SpS2.31
BVpS1.95
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.88%
ROE -11.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.88%
FCFM 7.99%
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 49.74%
Cap/Sales 7.81%
Interest Coverage N/A
Cash Conversion 119.47%
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 2.98
Altman-Z 2.35
F-Score5
WACC9.22%
ROIC/WACCN/A
Cap/Depr(3y)71.79%
Cap/Depr(5y)97.26%
Cap/Sales(3y)9.92%
Cap/Sales(5y)10.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y83.77%
EPS Next 2Y38.49%
EPS Next 3Y30.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-19.43%
Revenue Next Year-12.4%
Revenue Next 2Y-5.77%
Revenue Next 3Y-2.88%
Revenue Next 5Y-5.05%
EBIT growth 1Y-274.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.34%
EBIT Next 3Y66.58%
EBIT Next 5Y49.12%
FCF growth 1Y20.16%
FCF growth 3YN/A
FCF growth 5Y16.46%
OCF growth 1Y-11.57%
OCF growth 3Y10.52%
OCF growth 5Y4.85%